ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes

about

Thiol/Disulfide Balance in Patients with Familial Hypercholesterolemia.

P2860

Q55621802-38270E7A-785A-4D50-AE07-7D9974652FD5

P2860

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes

Item

http://www.wikidata.org/entity/Q41118450

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

ANMCO Scientific Statement: cl ...... with acute coronary syndromes

@en

type

Item

label

ANMCO Scientific Statement: cl ...... with acute coronary syndromes

@en

prefLabel

ANMCO Scientific Statement: cl ...... with acute coronary syndromes

@en

P1476

ANMCO Scientific Statement: cl ...... with acute coronary syndromes

@en

P2093

Carmine Riccio

http://www.w3.org/2001/XMLSchema#string

Federico Nardi

http://www.w3.org/2001/XMLSchema#string

Gian Francesco Mureddu

http://www.w3.org/2001/XMLSchema#string

Gian Piero Perna

http://www.w3.org/2001/XMLSchema#string

Italian Association of Hospital Cardiologists (ANMCO)

http://www.w3.org/2001/XMLSchema#string

Marcello Arca

http://www.w3.org/2001/XMLSchema#string

Maurizio Giuseppe Abrignani

http://www.w3.org/2001/XMLSchema#string

Michele Massimo Gulizia

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.

Lipid levels after acute coronary syndromes.

Long-term outcomes and causes of death after acute coronary syndrome in patients in the Bologna, Italy, area.

P304

D64-D69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/SUX018

http://www.w3.org/2001/XMLSchema#string

P433

Suppl D

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Furio Colivicchi

P577

2017-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28751835

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

5526473

http://www.w3.org/2001/XMLSchema#string

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes

about

P2860

P2860

ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932